Advertisement

Topics

Teva Parenteral Medicines Company Profile

16:04 EDT 21st June 2018 | BioPortfolio


News Articles [1377 Associated News Articles listed on BioPortfolio]

Teva Pharma: EMA To Review Marketing Authorization For Fremanezumab

PETAH TIKVA (dpa-AFX) - Teva Pharmaceutical Industries Ltd., (TEVA) announced the European Medicines Agency has accepted the Marketing Authorization Application for fremanezumab, an anti-calcitoni...

Teva Announces Launch of an Authorized Generic of Estrace Cream in the United States

This launch is an important addition to Teva's generic women's health portfolio and our growing line of menopause treatments. With nearly 600 generic medicines available, Teva has the largest ...

Teva to Present at the Cowen & Company 38th Annual Healthcare Conference

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) will host a live audio webcast at the Cowen & Company 38th Annual Healthcare Conference in Boston, MA. ...

Teva and Procter & Gamble Company terminate PGT Healthcare partnership

Teva Pharmaceutical Industries has announced that Teva and the Procter & Gamble Company have agreed to terminate the PGT Healthcare partnership that the two companies established in 2011 to market OTC...

Hikma brings on former Teva generics leader as CEO

Teva To Discontinue Clinical Trial Of Fremanezumab For Chronic Cluster Headache

Israeli generic medicines producer Teva Pharmaceutical Industries (TEVA) announced Friday that it will discontinue the trial of fremanezumab for use in chronic cluster headache, which is part of the l...

EMA to review Teva's MAA for migraine prevention drug fremanezumab

Teva Pharmaceutical Industries' marketing authorization application (MAA) for fremanezumab has been accepted by the European Medicines Agency (EMA) for the prevention of episodic and chronic migraine ...

Teva Pharmaceutical Industries (TEVA) Lifted to "Strong-Buy" at ValuEngine

Several other equities analysts also recently weighed in on TEVA. Oppenheimer reissued a "hold" rating on shares of Teva Pharmaceutical Industries in a research report on Wednesday, October 4th.

Drugs and Medications [285 Associated Drugs and Medications listed on BioPortfolio]

Silver nitrate [Teva Pharmaceuticals USA Inc]

SILVER NITRATE Solution

Terbinafine hydrochloride [Aurobindo Pharma Limited]

These highlights do not include all the information needed to use terbinafine hydrochloride safely and effectively. See full prescribing information for terbinafine hydrochloride tablets.Terbinafine H...

Nicotine polacrilex [IVAX Pharmaceuticals Inc]

Nicotine polacrilex [IVAX Pharmaceuticals Inc]

Gemcitabine hydrochloride [Teva Parenteral Medicines, Inc.]

These highlights do not include all the information needed to use Gemcitabine for Injection, USP safely and effectively. See full prescribing information for Gemcitabine for Injection, USP. Gemcitabin...

PubMed Articles [386 Associated PubMed Articles listed on BioPortfolio]

Higher versus lower amino acid intake in parenteral nutrition for newborn infants.

Sick newborn and preterm infants frequently are not able to be fed enterally, necessitating parenteral fluid and nutrition. Potential benefits of higher parenteral amino acid (AA) intake for improved ...

Essential medicines availability is still suboptimal in many countries: A scoping review.

To identify uses of WHO Model list of essential medicines (EM) and summarize studies examining essential medicines (EM) and national EM lists (NEMLs).

Adolescents' knowledge and perception of risk toward medicines.

Adolescents often start to use medicines independently without having sufficient knowledge or previous experience, which can lead to the inappropriate use of the medicines.

Parenteral nutrition in intensive care patients: medicoeconomic aspects.

Parenteral nutrition alone or as supplemental parenteral nutrition (SPN) has been shown to prevent negative cumulative energy balance, to improve protein delivery and, in some studies, to reduce infec...

Gut Microbiota as a Modulator of Paneth Cells During Parenteral Nutrition in Mice.

Parenteral nutrition (PN) leads to decreased production of Paneth cell-derived antimicrobial peptides and is accompanied by dysbiosis of the gut. The role of gut microbiota in regulating Paneth cell f...

Clinical Trials [732 Associated Clinical Trials listed on BioPortfolio]

Low Dose Parenteral Fat for Prevention of Parenteral Nutrition Associated Cholestasis in Preterm Neonates

The goal of the study is to determine if parenteral nutrition-associated cholestasis (PNAC) is related to the amount of parenteral (intravenous) fat administered to premature babies until ...

Early Versus Late Parenteral Nutrition in the Pediatric Intensive Care Unit

In the PEPaNIC trial it is investigated whether withholding parenteral nutrition during the first week in critically ill children is beneficial, compared to the current standard of the ear...

A Trial of Taurine Supplementation in Parenteral Nutrition 1

The purpose of this study is to investigate whether the inclusion of 1g of intravenous taurine as part of the nitrogen source of parenteral nutrition reduces parenteral nutrition associate...

Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents

This multicenter observational cohort study proposes to establish the risks of short and long-term outcomes in users of parenteral micafungin and in users of other parenteral antifungal ag...

Evaluation of Omegaven™ Parenteral Nutrition in Patients With TPN-Induced Cholestasis

The purpose of this study is to determine if established parenteral nutrition (PN) associated liver disease can be reversed or its progression halted by using a parenteral fat emulsion pre...

Companies [633 Associated Companies listed on BioPortfolio]

Teva Parenteral Medicines

Teva North America Specialty Medicines

Teva Pharmaceutical Industries Ltd is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of patients every day. I...

Teva Neuroscience Inc.

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and...

Teva USA

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and ...

Teva Women’s Health, Inc.

Teva Women’s Health, Inc. is a U.S.-based subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), headquartered in Israel. The company produces a wide range of women...

More Information about "Teva Parenteral Medicines" on BioPortfolio

We have published hundreds of Teva Parenteral Medicines news stories on BioPortfolio along with dozens of Teva Parenteral Medicines Clinical Trials and PubMed Articles about Teva Parenteral Medicines for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Teva Parenteral Medicines Companies in our database. You can also find out about relevant Teva Parenteral Medicines Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record